Aflibercept in the treatment of diabetic macular edema: a review and consensus paper.

about

Aflibercept in the treatment of diabetic macular edema: a review and consensus paper.

Item

http://www.wikidata.org/entity/Q50095639

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Aflibercept in the treatment of diabetic macular edema: a review and consensus paper.

@en

Aflibercept in the treatment of diabetic macular edema: a review and consensus paper.

@nl

type

Item

label

Aflibercept in the treatment of diabetic macular edema: a review and consensus paper.

@en

Aflibercept in the treatment of diabetic macular edema: a review and consensus paper.

@nl

prefLabel

Aflibercept in the treatment of diabetic macular edema: a review and consensus paper.

@en

Aflibercept in the treatment of diabetic macular edema: a review and consensus paper.

@nl

P1476

Aflibercept in the treatment of diabetic macular edema: a review and consensus paper.

@en

P2093

Diego Fornasari

http://www.w3.org/2001/XMLSchema#string

Edoardo Midena

http://www.w3.org/2001/XMLSchema#string

Federico Ricci

http://www.w3.org/2001/XMLSchema#string

Francesco Boscia

http://www.w3.org/2001/XMLSchema#string

Giovanni Staurenghi

http://www.w3.org/2001/XMLSchema#string

Leonardo Mastropasqua

http://www.w3.org/2001/XMLSchema#string

Monica Varano

http://www.w3.org/2001/XMLSchema#string

Paolo Lanzetta

http://www.w3.org/2001/XMLSchema#string

Teresio Avitabile

http://www.w3.org/2001/XMLSchema#string

P2860

Role of implants in the treatment of diabetic macular edema: focus on the dexamethasone intravitreal implant

Systematic review and mixed treatment comparison of intravitreal aflibercept with other therapies for diabetic macular edema (DME)

Placental growth factor contributes to micro-vascular abnormalization and blood-retinal barrier breakdown in diabetic retinopathy

Inducible nitric oxide synthase isoform is a key mediator of leukostasis and blood-retinal barrier breakdown in diabetic retinopathy.

Diabetic macular edema: pathogenesis and treatment.

The DA VINCI Study: phase 2 primary results of VEGF Trap-Eye in patients with diabetic macular edema.

The discovery of placenta growth factor and its biological activity.

Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders.

Prevalence of and risk factors for diabetic macular edema in the United States.

Deletion of placental growth factor prevents diabetic retinopathy and is associated with Akt activation and HIF1α-VEGF pathway inhibition.

P304

627-639

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.5301/EJO.5001053

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Claudio Azzolini

Sandro De Falco

Francesco Bandello

P577

2017-10-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29077188

http://www.w3.org/2001/XMLSchema#string